Comparison Overview
AbbVie | Neuroscience

AbbVie | Neuroscience
N/A
Last Update: 19/03/2026
Follow AbbVie’s Neuroscience page for news and updates about our commitment to help those living with and affected by the realities of neurological and psychiatric disorders such as Alzheimer’s disease, bipolar disorder and depression, major depressive disorder, migrain...

SUN PHARMA
Sun House, CTS No. 201 B/1,, Mumbai, 400063, IN
Last Update: 01/04/2026
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufa...
Compliance Ranges Comparison

AbbVie | Neuroscience







SUN PHARMA






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AbbVie | Neuroscience in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for SUN PHARMA in 2026.
Incident History - AbbVie | Neuroscience (X = Date, Y = Severity)
AbbVie | Neuroscience cyber incidents detection timeline including parent company and subsidiaries.
Incident History - SUN PHARMA (X = Date, Y = Severity)
SUN PHARMA cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

AbbVie | Neuroscience

SUN PHARMA
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.